Coronavirus Strategies to Boost Community Coronavirus Strategies to Boost Community

ADVERTISEMENT

Is Nerve Damage The Rule, Not the Exception With Cholesterol Meds?

Is Nerve Damage The Rule, Not the Exception With Cholesterol Meds?

Story at-a-glance -

  • A new study found treatment with statin cholesterol-lowering drugs caused a clinically silent but still definite damage to peripheral nerves when taken for longer than 2 years
  • At least 88 other studies further link statin drugs to neurotoxicity (nerve damage), including 12 studies on statin-induced peripheral neuropathy
  • A separate study published in the Archives of Internal Medicine revealed statins increase the risk of diabetes for postmenopausal women by 48 percent, adding to an already established body of research on their diabetogenic properties
  • More than <i>255 million</i> prescriptions were dispensed for cholesterol-lowering drugs in 2010, making them the most commonly prescribed type of medication in the United States; however, for the vast majority of people they are unnecessary, often causing more harm than good
  • Your body needs cholesterol, and using drugs to lower it as low as it will go is not usually beneficial for your health; you can <i>optimize</i> your cholesterol levels so they're working in the proper balance with your body using natural lifestyle modifications

By Dr. Mercola

Spending on cholesterol-lowering drugs like statins increased by $160 million in 2010, for a total spending of nearly $19 billion in the U.S., the IMS Institute for Healthcare Informatics reported in their Use of Medicines in the United States: Review of 2010.


Read the Full Article for Free!
Subscribe to the #1 Natural Health Newsletter
  • Unlock censored health information that Google doesn't want you to read
  • Keep your privacy secure — We are no longer active on Facebook and are blocking our content from Google search to ensure your privacy stays protected
  • Get access to all of Dr. Mercola's health articles, E-books and special reports

Existing Subscribers: Enter your email address for instant access